C2ORF44 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.280700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.641800E-01
Normal-vs-Stage2
9.758200E-03
Normal-vs-Stage3
6.953900E-02
Normal-vs-Stage4
7.568000E-01
Stage1-vs-Stage2
2.338200E-01
Stage1-vs-Stage3
4.707600E-02
Stage1-vs-Stage4
2.436400E-01
Stage2-vs-Stage3
1.005970E-01
Stage2-vs-Stage4
1.779670E-02
Stage3-vs-Stage4
1.801520E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.215700E-02
Normal-vs-AfricanAmerican
1.201790E-01
Normal-vs-Asian
1.076350E-02
Caucasian-vs-AfricanAmerican
8.501400E-01
Caucasian-vs-Asian
7.786300E-02
AfricanAmerican-vs-Asian
2.915400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.101590E-02
Normal-vs-Female
3.071000E-01
Male-vs-Female
3.201000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.521600E-01
Normal-vs-Age(41-60Yrs)
3.659600E-01
Normal-vs-Age(61-80Yrs)
6.196400E-03
Normal-vs-Age(81-100Yrs)
5.222400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.254800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.581000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.584600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.476600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.165000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.211400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.399500E-03
Normal-vs-Daily Drinker
2.076200E-02
Normal-vs-Weekly Drinker
4.798000E-02
Normal-vs-Occasional Drinker
3.065800E-01
Normal-vs-Social Drinker
1.345780E-01
Non Drinker-vs-Daily Drinker
9.483000E-01
Non Drinker-vs-Weekly Drinker
3.282200E-01
Non Drinker-vs-Occasional Drinker
1.604650E-01
Non Drinker-vs-Social Drinker
3.355500E-02
Daily Drinker-vs-Weekly Drinker
4.295600E-01
Daily Drinker-vs-Occasional Drinker
2.502800E-01
Daily Drinker-vs-Social Drinker
7.416400E-02
Weekly Drinker-vs-Occasional Drinker
8.176400E-01
Weekly Drinker-vs-Social Drinker
3.191000E-01
Occasional Drinker-vs-Social Drinker
3.335600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.095800E-01
Normal-vs-Grade 2
8.061400E-01
Normal-vs-Grade 3
7.150600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.531200E-01
Grade 1-vs-Grade 3
9.418400E-02
Grade 1-vs-Grade 4
6.095800E-01
Grade 2-vs-Grade 3
1.028840E-01
Grade 2-vs-Grade 4
8.061400E-01
Grade 3-vs-Grade 4
7.150600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.715960E-02
Normal-vs-NonDiabetic
2.673400E-01
Diabetic-vs-NonDiabetic
9.100400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.223240E-01
Normal-vs-NoPancreatitis
2.637000E-01
Pancreatitis-vs-NoPancreatitis
3.326000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.219700E-02
Normal-vs-N1
7.960700E-03
N0-vs-N1
9.433800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.265600E-01
Normal-vs-TP53-NonMutant
6.285900E-02
TP53-Mutant-vs-TP53-NonMutant
7.068800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
